Low-frequency blood pressure oscillations (Mayer waves) are discussed as a marker for sympathetic modulation of vascular tone. However, the factors that determine the frequency response of the vasculature to sympathetic stimuli are not fully understood. Possible mechanisms include functions related to 1 -adrenergic receptors ( 1 -AR) and post-receptor processes involved in the vascular contractile response. The purpose of the present study was to examine the hypothesis that expression levels of 1 -AR and their subtype distribution determine velocity and magnitude of 1 -AR-mediated vascular smooth muscle cell (VSMC) contraction.
Introduction
It is under debate whether low-frequency blood pressure oscillations, also referred to as Mayer waves, are a useful parameter for the estimation of sympathetic modulation of vascular tone.
The association of peripheral sympathetic outflow and low-frequency blood pressure variability has been demonstrated by microneurographic techniques (11; 32; 44) . Moreover, frequency and amplitude of Mayer waves can be altered in a variety of pathological conditions, such as diabetes (17), congestive heart failure (37), acute brain injury (13) , and hypertension (33).
However, despite these findings, relatively little is known regarding the underlying physiology of these oscillations (24).
Short-term control of arterial pressure is achieved by a variety of regulatory systems that rely on sympathetic pathways, endothelial factors, angiotensin II, and others (34). The role of these factors in blood pressure regulation is often studied by the power spectral approach (5; 30; 36; 41) . With this technique, the contribution of blood pressure fluctuations at specific frequencies to the overall blood pressure variability is assessed. The general idea is that different blood pressure regulatory systems can modulate arterial pressure only in very specific frequency ranges.
One of several sources causing blood pressure variability originates from sympathetic-mediated vasomotions. These vascular reactions are elicited by contractions and relaxations of vascular smooth muscle cells (VSMCs) in response to periodic stimulation of 1 -adrenergic ( 1 -AR) (3) or other (e.g. purinergic) (10) receptors by sympathetic transmitters. The presence of the resulting blood pressure oscillations between 0.1 and 0.4 Hz requires that sympathetic transmission to the vasculature is rapid enough to mediate fluctuations in this frequency range.
Experiments in healthy rats using electrical stimulation of the paraventricular nucleus of the hypothalamus at multiple frequencies while recording splanchnic nerve activity and mesenteric blood flow suggest that the rate-limiting step of sympathetic-mediated blood pressure oscillations lies not at the central or sympathetic nervous system site but in the vascular (42) . A more recent study using isolated rat aortic VSMCs suggests that the time course of sympathetic-mediated smooth muscle cell contraction may be limited by mechanisms related to 1 -AR (25). However, the specific factors determining velocity and magnitude of sympathetic-mediated vasoconstriction and, therefore, underlying the different frequency response characteristics in various physiological and pathological conditions remain to be elucidated.
The goal of the present study was to test the hypothesis that 1 -AR density and expression of the three subtypes 1A , 1B , and 1D determine magnitude and velocity of 1 -AR-mediated smooth muscle contraction. To examine the role of receptor-independent mechanisms, we induced contractions by membrane depolarization with KCl.
Materials and Methods

Animals
For experiments, six-week-old male Sprague-Dawley rats (Charles River Laboratories, Sulzfeld, Germany) were used. After shipping, rats were housed in the institutional animal care facility under standardized conditions for at least one week prior to experiments. All studies were approved by the federal animal rights committee and were performed in accordance with institutional guidelines for health and care of experimental animals.
Materials
Mammalian expression vectors containing the 1 -AR genes were kindly provided by Dr. Robert J. Lefkowitz (Duke University Medical Center, Durham, NC, USA): pBC12BI 1A/C ( 1A -AR, bovine) (40), pBC12BI 1B ( 1B -AR, hamster) (6), and pCMV5 1 RA42 ( 1D -AR, rat) (29) . The pEGFP-C1 expression vector was obtained from CLONTECH, Heidelberg, Germany.
Subtype-selective goat polyclonal 1 -AR antibodies raised against residues in the cytoplasmatic tail of the 1 -AR were obtained from Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA.
The rabbit pan-specific 1 -AR antibody raised against residues in the third intracellular loop of 1 -AR was purchased from Alexis Deutschland GmbH, Grünberg, Germany.
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from Sigma, Taufkirchen, Germany; VECTASHIELD Mounting Medium with DAPI from Alexis Deutschland GmbH, Grünberg, Germany; and Texas Red-labeled secondary antibody (rabbit anti-goat) from Acris GmbH, Hiddenhausen, Germany.
Cell Isolation and Transient Transfection
Rats were anesthetized with pentobarbital sodium (150 mg/kg i.p.), and the thoracic aorta was quickly removed. Aortic cells were isolated by collagen dispersion and propagated in gelatincoated Lab-Tek TM Chamber Slide TM Systems (Nunc, Wiesbaden, Germany) at 37°C in a humidified 5% CO 2 incubator in DMEM supplemented with 100 units/ml penicillin, 100 µg/ml streptomycin, 10% foetal bovine serum, and 5% horse serum. Cells were grown to approximately 50% confluence and used for experiments 5 days after being plated. Characterization of VSMCs was performed by -smooth muscle actin immunostaining using the monoclonal anti--Sm-1 mouse IgG2a (clone 1A4; Sigma).
Vectors containing one of the three 1 -AR subtypes were transfected into VSMCs together with cDNA encoding a green fluorescent protein (EGFP), which served for detection of transfected cells. The ratio of 1 -AR and EGFP plasmid concentration was 10 µg/ml to 1.0 µg/ml in order to increase the probability of 1 -AR coexpression in EGFP-positive cells. Controls were transfected with cDNA for EGFP only. Transfection was accomplished by incubation of cells in serum-free DMEM with cDNA (11.0 µg/ml) and DMRIE-C (33 µl/ml) at 37°C for 6 hours. The process was terminated by incubation of cells in DMEM containing 10% foetal bovine serum and 5% horse serum for 1 hour. To maintain a contractile phenotype of cells, the medium was subsequently exchanged for serum-free DMEM and cells were incubated for 36-48 hours before they were used for immunocytochemical and functional studies. Alexa 594 fluorescence an argon-krypton-laser at a wavelength of 568 nm was used. The setting on the laser was constant for all experiments. Only cells of the same rat that were located on one glass slide and which all underwent the same immunocytochemical protocol, were compared.
Images were stored on an optical disk as eight-bit, 512-483 pixel tagged image file format files and transferred to a personal computer for off-line analysis.
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Functional Studies
Ten rats were used for functional cell culture studies. From each rat, 1-3 cells per group were investigated. Spindle-shaped EGFP-positive cells were selected by fluorescence microscopy.
During experiments, cells were monitored under brightfield conditions by a video camera mounted on a microscope (Zeiss, Axiovert S 100). The magnification resulted from a 40x objective lens and projection (1x) on a 0.3" chip digital camera. The spatial resolution was 0.2 µm. The video sequences were captured to a personal computer by a frame grabber card at 2 frames per second. The cell culture medium was replaced by oxygenated and carbonated Krebs' buffer (118.3 mM NaCl / 4.7 mM KCl / 2.5 mM CaCl 2 / 1.2 mM MgSO 4 / 1.2 mM KH 2 PO 4 / 25 mM NaHCO 3 / 11 mM glucose) and adjusted to 37°C by heating the stage of the microscope. First, contraction was elicited by bolus application of high KCl solution (100 mM). The concentration was selected to be high enough to ensure maximal contraction. Subsequently, non-cumulative concentration-response curves were generated for changes in cell length and contraction velocity in response to bolus application of increasing doses of the selective 1 -AR agonist phenylephrine (1 nM, 10 nM, 100 nM, 1 µM, 10 µM, 100 µM). Cells that disconnected from the surface or showed significant morphological changes during successive applications of phenylephrine were excluded from data analysis. Application of Krebs' buffer alone did not induce significant contractions.
Data Analysis Immunocytochemistry
The fluorescent intensity of the cell boundary was measured in a constant-sized rectangular area adjacent to the cell surface using the image analysis software NIH Image J 1. 
Functional Studies
The video sequences were analysed using imaging software (Khoros, Khoral Research, Inc., Albuquerque, NM) that generated time series of the cell length for each video frame (sampling rate 2 Hz). The cell length time series ( (t)) were fitted to the following four-parameter logistic response function:
In this function, the parameter B represents the basal length, C equals the length in the 
Statistical Analysis
Differences between groups were determined by one-way ANOVA followed by the Bonferroni test for multiple comparisons. Since comparisons were made between 4 groups, critical was reduced to 0.0125.
Results
-Adrenoceptor Expression in Vascular Smooth Muscle Cells
Subtype-selective antibodies were used to examine the membrane expression of individual 1 Immunofluorescence produced by the anti-1B -AR antibody was 257±28% of control in cells transfected with the corresponding 1B -AR subtype, while it was only 110±10% for 1A -and 149±22% for 1D -AR-transfected cells ( 1B vs. 1A and control, respectively, p<0.001; 1B vs. 1D , respectively, p<0.01; n=12-14 in each group; Fig. 2 ). Fluorescent intensity produced by the anti-1D -AR antibody was 167±16% of control for the 1D -AR-transfected group, but only 107±10% and 111±9% of control for 1A -and 1B -AR-transfected groups ( 1D vs. 1A , 1B , and control, respectively, p<0.01; n=15-16 in each group; Fig. 2 ). Controls and cells transfected with plasmids encoding 1 -AR subtypes that did not correspond to the applied antibody did not differ in their fluorescent intensity suggesting that overexpression of one transfected receptor subtype was not associated with up-or downregulation of other subtypes.
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To determine overall 1 -AR expression including the endogenously expressed receptor fraction, immunostainings with a pan-specific 1 -AR antibody were performed. Compared with the control group, fluorescent intensity of the cell boundary was increased to 189±17%, 224±27%, and 201±15% for the 1A -AR, 1B -AR, and 1D -AR ( 1A and 1D vs. control, respectively, p<0.01; 1B vs. control, respectively, p<0.001; n=16-19 in each group; Fig. 3 ) suggesting increased overall 1 -AR expression levels in membranes of transfected cells. In contrast, no differences were found between the three transfected groups (Fig. 3) .
Contractile Responses of Vascular Smooth Muscle Cells
Basal cell length was 21.5±1.2 µm, 21.4±0.9 µm, 21.1±1.1 µm, and 22.0±1.2 µm for 1A -AR (n=16), 1B -AR (n=16), 1D -AR (n=17) , and control (n=15) and did not differ between groups (P>0.05). Cell length reduction in response to KCl (100 mM) was 2.37±0.23 µm (11.0±0.8%), There was also a dose-response relationship for contraction velocity to phenylephrine. Although sensitivity for this parameter did not differ between groups maximal velocity of contraction was almost 2-fold higher in transfected cells compared with the control group. E max was 86.5±3.2%, 99.0±4.4%, 89.5±7.1%, and 53.5±6.0% of KCl for 1A -AR, 1B -AR, 1D -AR, and control ( 1A , 1B , 1D vs. control, respectively; p<0.01; Fig. 5, right) 
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Discussion
Contractile velocity and magnitude of 1 -AR-transfected aortic VSMCs in response to phenylephrine, was investigated. We found that elevated 1 -AR expression density, irrespective of the expressed subtype, markedly enhanced velocity of contraction suggesting that regulation of receptor expression may be a possible mechanism determining the time course of sympathetic-mediated vasoconstriction. In contrast, a high 1 -AR expression level was associated with increased sensitivity but had no influence on maximal magnitude of contraction in VSMCs overexpressing each of the three cloned 1 -AR subtypes.
Recent experiments, in which isolated rat aortic VSMCs were periodically stimulated with either phenylephrine or KCl suggest that 1 -AR-mediated velocity of smooth muscle contraction may be rate-limiting for sympathetic-mediated vasomotions (25).
The present study confirms the previously reported observation that VSMCs endogenously expressing 1 -AR contract slower in response to phenylephrine than to KCl. Moreover, our results extend the previous findings (25) by suggesting that an elevation of the receptor expression level is associated with an increased velocity and sensitivity of cell contraction in response to phenylephrine. Thus, it is reasonable to assume that 1 -AR density of the vasculature determines its sympathetic responsiveness, which in turn may have an impact on the frequency and the amplitude of sympathetic-mediated blood pressure oscillations.
Chronic exposure to high levels of humoral catecholamines has been reported to depress vascular 1 -adrenergic receptor expression and responsiveness (27) suggesting a downregulation of these receptors by a negative autofeedback mechanism. In line with these findings other studies showed that vascular 1 -adrenergic responsiveness is reduced in a variety of physiological and pathophysiological conditions associated with increased sympathetic tone, e.g. advanced age (7; 20) , and congestive heart failure (1).
Interestingly, recent investigations in various cell models revealed that autofeedback regulation of 1 -AR differs considerably between subtypes. While in these experiments the 1A -and 1B -AR were downregulated after chronic exposure to phenylephrine, the expression level of the 1D -AR increased or remained unchanged following stimulation with this agonist (4; 47). Although much progress in identifying the interactions of 1 -AR with second messenger molecules has been made, it has proven extremely complex to discern the specific role of each 15 However, a simple extrapolation of the molecular biological findings may not be sufficient to explain the effects of these receptors on vascular contractility, since there may exist a nonlinear relationship between these factors. Recently, this issue has been addressed in a series of experiments on intact blood vessels. This study reported a non-parallelism between 1 -ARmediated IP formation and smooth muscle contraction in the rat aorta (12) , which is possibly a result of sensitization mediated by intracellular enzymes, such as Rho kinase and protein kinase C (31; 48). Moreover, there is convincing evidence for activation of other signaling pathways by 1 -AR. These include activation of phospholipase A2 and mitogen activated kinases (26; 45), production of reactive oxygen species (28) , and activation of NADPH oxidase (46) . Since these signal transduction cascades interact with each other as a network, the activation of one signal pathway can initiate, potentiate or inhibit other signaling systems, leading to a different functional response than expected from the increase of individual second messenger molecules.
Recent studies employing oligonucleotide microarrays demonstrated a number of 1 -AR subtype-specific changes in gene expression suggesting a link to independent signaling pathways for each subtype (14) . Since the expression pattern of 1 -AR varies between vascular beds, the distribution of signaling molecules involved in the 1 -AR-mediated contractile response is also likely to differ. Thus, other vascular tissues need to be tested to determine, whether our findings in aortic smooth muscle cells are global or vessel-specific.
Since cultured smooth muscle cells lack a variety of conditions determining cell differentiation and function in intact blood vessels, e.g. endothelial and extracellular matrix influences, gap junctions, and permanent transmitter stimulation, the impact of 1 In summary, the data of the present study suggest that 1 -AR density determines velocity and sensitivity of sympathetic-mediated contraction in VSMCs. In contrast, the various 1 -AR subtypes tested do not appear to influence vasoconstriction to sympathetic stimuli differently.
An altered vascular 1 -AR expression level may account for tissue-dependent differences in vascular sympathetic responsiveness as well as for frequency and amplitude changes of Mayer waves found in various pathological conditions. 
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